Facial Injectables Market Drivers and Opportunity Analysis By Global Eminent Players such as Allergan, Plc., Galderma S.A., Integra LifeSciences Corporation, Merz Pharma GmbH & Co. KGaA., Sanofi S.A., SciVision Biotech Inc.

Facial injectable aid in rejuvenating facial skin by reducing or eliminating wrinkles, raising scar depressions, and enhancing lips. Facial injectable are products that include collagen fillers, hyaluronic acid fillers, and synthetic fillers such as calcium hydroxyl apatite. The use of injectable products such as hyaluronic acid increases skin hydration, improves skin, and protects from UV damage and has relatively low side effects. These factors are anticipated to drive the market growth over the forecast years. Moreover, increasing demand for products that enhance personal beauty, rising consciousness about aesthetics, introduction of cost-effective facial injectable, and growing inclination towards minimally invasive procedures is anticipated to fuel the market growth.

The global facial injectables market was valued at US$ 6,253.7 million in 2016 and is expected to exhibit a robust CAGR of 11.9% over the forecast period (2017–2025).

Get Free Exclusive PDF Brochure of This Report: https://www.coherentmarketinsights.com/insight/request-pdf/1329

Market Dynamics

Major factors driving growth of the facial injectables market include increasing preference for non-surgical invasive cosmetics surgeries, increasing FDA approval of novel products, and rising demand for facial injectable to enhance aesthetic beauty. For instance, in 2017, Allergan Plc. received FDA approval for Juvederm Vollure for use in the U.S., while the product was previously available in Europe. Moreover, increasing promotional activities, rapidly developing healthcare infrastructure, and rising disposable income are the factors to propel the facial injectables market. For instance, according to the American Society for Aesthetic Plastic Surgery (ASAPS), 2016, the people in the U.S. spend over US$ 15 billion on combined surgical and non-surgical aesthetic procedures, accounting for an 11% increase over the year 2015. However, stringent regulations and side effects associated with injectable such as bruising, discoloration, and rashes are expected to negatively affect the market growth.

Increasing preference for non-invasive procedures to augment market growth

Increasing demand for non-surgical procedures for facial rejuvenation and correction is expected to be a factor augmenting growth of the facial injectables market. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS), 2017, surgical and non-surgical cosmetic procedures exhibited an overall increase of 9% from 2016-2017. ISAPS also stated that nonsurgical procedures including injectable accounted for around 8,548,597 in 2016, globally. According to the British Association of Aesthetic Plastic Surgeons, 2013, anti-ageing facelifts and brow lifts cosmetic operations exhibited a 17% rise as compared to the year 2012 globally, thus indicating rise in adoption of facial injectable.

Request For Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/1329

Supportive government and non-government initiatives to accelerate the market growth

Various organizations are conducting educational programs, scientific meetings to provide knowledge about the latest research and procedures, in turn increasing awareness among patients and plastic surgeons, thus bolstering the market growth. For instance, the International Society of Aesthetic Plastic Surgery (ISAPS) is a professional organization for board-certified aesthetic plastic surgeons, dedicated to promote excellence in the field of aesthetic plastic surgery globally. The Society offers instructional courses, symposia, and educational programs, while the members of ISAPS have access to the most advanced techniques such as botulinum toxin and dermal fillers.

Competitive landscape

Major players operating in the global facial injectables market are Allergan, Plc., Galderma S.A., Integra LifeSciences Corporation, Merz Pharma GmbH & Co. KGaA., Sanofi S.A., SciVision Biotech Inc., Sinclair Pharma Plc., Suneva Medical, Valeant Pharmaceuticals International, Inc., and Anika Therapeutics, Inc.

Detailed Segmentation:

Global Facial Injectables Market, By Product Type:

Dermal Fillers
- Hyaluronic Acid Fillers
- Collagen Fillers
- Synthetic Fillers
Anti-wrinkle Injection
- Botulinum Toxin A
- Poly-L-lactic Acid (PLLA)

Global Facial Injectables Market, By Application:

Wrinkle Reduction
Facelift
Lip Enhancement
Others

Find the comprehensive research report here with a single click: https://www.coherentmarketinsights.com/market-insight/facial-injectables-market-1329

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.